Global Regulatory Scrutiny Will Undermine MLM And Supplement Models

Key Takeaways

• Rising regulatory scrutiny and shifting consumer preferences threaten future growth, profitability, and increase compliance costs for the company's traditional business model.
  
• Flat volumes, maturing markets, and negative MLM perceptions undermine growth initiatives, leaving revenue and margins vulnerable to macroeconomic volatility.
  
• Emphasis on innovation, technology, and distributor engagement is boosting operational efficiency, customer retention, and financial flexibility amid rising demand for personalized wellness solutions.

Catalysts

Provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific.

• Investors may be underestimating the risk of increasing global regulatory scrutiny on multi-level marketing (MLM) models and nutritional supplement claims, which could raise compliance costs, limit distributor activity in key regions, and constrain Herbalife's long-term revenue and earnings growth.
  
• Secular consumer trends toward whole, natural foods and growing skepticism of processed supplements may impair demand for Herbalife's core products, potentially leading to slower revenue growth and higher customer acquisition costs as consumer preferences evolve.
  
• The company continues to experience flat to declining volumes in several regions, with only modest improvements in constant currency net sales, indicating that the addressable market for Herbalife's traditional model may be reaching maturity and that top-line revenue growth could remain pressured.
  
• Ongoing reliance on network recruiting and regional distributor growth increases vulnerability to macroeconomic downturns and currency headwinds in emerging markets, which may result in heightened volatility in both revenue and net margins.
  
• Challenges in breaking away from negative public perceptions around the MLM structure and hesitancy in successfully transforming into a technology-focused, personalized wellness platform could limit the effectiveness of current growth initiatives-constraining long-term sales expansion and profit margin improvement.

Herbalife Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Herbalife's revenue will grow by 4.3% annually over the next 3 years.
• Analysts assume that profit margins will shrink from 6.6% today to 2.5% in 3 years time.
• Analysts expect earnings to reach $137.6 million (and earnings per share of $1.32) by about August 2028, down from $325.0 million today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 10.2x on those 2028 earnings, up from 3.1x today. This future PE is lower than the current PE for the US Personal Products industry at 20.4x.
• Analysts expect the number of shares outstanding to grow by 2.37% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 12.32%, as per the Simply Wall St company report.

Herbalife Future Earnings Per Share Growth

Risks

• Herbalife's transformation into a next-generation, data-driven wellness company-including its investments in product innovation (e.g., healthy lifespan supplements, MultiBurn) and personalized technology platforms (Pro2col, Link Biosciences)-positions it to capitalize on the major secular trend of rising consumer demand for personalized and preventative health solutions, potentially leading to increased revenue and higher customer retention.
  
• The company is seeing early signs of accelerating momentum in key markets, particularly North America, with July marking the first month of year-over-year volume growth in the region since 2021, which could signal a reversal of past declines and bolster top-line growth.
  
• Expansion of digital engagement, AI-driven marketing, subscription-based offerings, and enhanced distributor tools is increasing operational efficiencies and recurring revenues, supporting improved net margins and cash flow generation over the longer term.
  
• Strong engagement and stability within the distributor network-evidenced by flat global new distributor growth, high engagement at major events, and enthusiastic adoption of new technology-demonstrate resilience and adaptability of the business model, reducing downside risk to earnings.
  
• Ongoing debt reduction and disciplined capital management, including paying down $55 million of debt this quarter and maintaining leverage at 3x, leaves Herbalife in a stronger financial position, providing flexibility for future investment and potentially supporting sustained earnings and shareholder value.

Valuation

• The analysts have a consensus price target of $9.0 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $11.0, and the most bearish reporting a price target of just $7.0.
  
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $5.6 billion, earnings will come to $137.6 million, and it would be trading on a PE ratio of 10.2x, assuming you use a discount rate of 12.3%.
  
• Given the current share price of $9.75, the analyst price target of $9.0 is 8.3% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.